Arlan Biotech

Arlan Biotech is a Lithuania-based biotechnology company specializing in the discovery and development of nanobodies using an AI-driven platform. The company leverages advanced machine learning algorithms to accelerate the identification of high-affinity single-domain antibodies for diagnostic and therapeutic applications. Their technology aims to significantly reduce the time and cost associated with traditional antibody discovery methods. Arlan Biotech focuses on a range of indications, including infectious diseases and oncology, while also providing custom nanobody discovery services to partners. The company's portfolio includes nanobodies targeting the SARS-CoV-2 spike protein and various diagnostic markers. By combining biological expertise with computational power, Arlan Biotech is positioning itself as a leader in the next generation of antibody engineering.